AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED

Company Introduction:

AUROBINDO PHARMA LIMITED is a leading Indian multinational pharmaceutical manufacturing company. Headquartered in HITEC City, Hyderabad, India, it is one of the top pharmaceutical companies globally. The company develops, manufactures, and markets a wide range of generic pharmaceuticals and active pharmaceutical ingredients (APIs) across various therapeutic areas. Aurobindo Pharma is known for its strong presence in key markets such as the United States, Europe, and emerging markets. Its product portfolio includes oral solids, injectables, over-the-counter (OTC) products, and biosimilars. The company has a robust research and development focus, multiple manufacturing facilities approved by global regulatory bodies, and a commitment to providing affordable and high-quality medicines.

Nature of Business:

AUROBINDO PHARMA LIMITED is a factory. It is a pharmaceutical manufacturer.

Aurobindo Pharma Limited manufactures and sells a diverse range of pharmaceutical products. These primarily fall into two broad categories: Active Pharmaceutical Ingredients (APIs) and Formulations (finished dosage forms).

Their product portfolio includes:

Active Pharmaceutical Ingredients APIs: The company produces various active pharmaceutical ingredients which are the fundamental chemical components used in the manufacture of medicines.

Formulations Finished Dosage Forms: Aurobindo Pharma offers a comprehensive range of finished dosage forms across numerous therapeutic areas. These include:

Anti-infectives: Products targeting bacterial, fungal, and viral infections. This segment notably includes a significant presence in Anti-Retroviral ARV drugs for HIV treatment, as well as various Cephalosporins and Penicillins.

Cardiovascular: Medications designed for the treatment of heart and blood vessel conditions, such as hypertension, heart failure, and dyslipidemia.

Central Nervous System CNS: Drugs addressing neurological and psychiatric disorders, including but not limited to antidepressants, anxiolytics, and antiepileptics.

Gastroenterology: Products for digestive system disorders, covering conditions like acid reflux, ulcers, and irritable bowel syndrome.

Anti-diabetics: Medicines specifically developed for the management and treatment of diabetes.

Oncology: A developing portfolio of drugs used in the treatment of various types of cancer.

Dermatology: Both topical and oral treatments for a range of skin conditions.

Respiratory: Medications for respiratory illnesses such as asthma and chronic obstructive pulmonary disease COPD.

Urology: Products for conditions affecting the urinary tract system.

Other Key Product Types: The company also produces a variety of sterile injectables, non-sterile oral solids, and other specialized pharmaceutical formulations.